News & storiesCheck out our latest stories2020-07-15Corporate newsOctapharma statement on social justice2020-05-20Press releaseFDA approves Octapharma USA investigational new drug application for severe COVID-19 patients2020-04-06Press releaseOctapharma acts to accelerate development of COVID-19 plasma therapies2020-03-06Press releaseOctapharma USA extends funding for COVID-19 study Study in California utilizing IVIG as investigational coronavirus treatment for adults experiencing respiratorShow more
2020-05-20Press releaseFDA approves Octapharma USA investigational new drug application for severe COVID-19 patients
2020-03-06Press releaseOctapharma USA extends funding for COVID-19 study Study in California utilizing IVIG as investigational coronavirus treatment for adults experiencing respirator
Patient engagementOctapharma takes an active role in our communityWe sponsor and support organizations worldwide.Learn how we engage with patients
Our productsProductsLearn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.Learn more